Evidence map›Paper›PMID 27295336›Full record

ArticleGenesis (New York, N.Y. : 2000)2016

A compact unc45b-promoter drives muscle-specific expression in zebrafish and mouse.

Steven Rudeck, Christelle Etard, Muzamil M Khan, Wolfgang Rottbauer, Rüdiger Rudolf, Uwe Strähle, Steffen Just

Open access · hybridAbstract readLetter
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Steven RudeckMolecular Cardiology, Department of Internal Medicine II, University of Ulm, Ulm, Germany.
Christelle EtardInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Muzamil M KhanMolecular Cardiology, Department of Internal Medicine II, University of Ulm, Ulm, Germany.
Wolfgang RottbauerDepartment of Internal Medicine II, University of Ulm, Ulm, Germany.
Rüdiger RudolfInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Uwe SträhleInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Steffen JustMolecular Cardiology, Department of Internal Medicine II, University of Ulm, Ulm, Germany.
Karlsruhe Institute of Technology · DEUniversität Ulm · DEHeidelberg University · DEUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene therapeutic approaches to cure genetic diseases require tools to express the rescuing gene exclusively within the affected tissues. Viruses are often chosen as gene transfer vehicles but they have limited capacity for genetic information to be carried and transduced. In addition, to avoid off-target effects the therapeutic gene should be driven by a tissue-specific promoter in order to ensure expression in the target organs, tissues, or cell populations. The larger the promoter, the less space will be left for the respective gene. Thus, there is a need for small but tissue-specific promoters. Here, we describe a compact unc45b promoter fragment of 195 bp that retains the ability to drive gene expression exclusively in skeletal and cardiac muscle in zebrafish and mouse. Remarkably, the described unc45b promoter fragment not only drives muscle-specific expression but presents heat-shock inducibility, allowing a temporal and spatial quantity control of (trans)gene expression. Here, we demonstrate that the transgenic expression of the smyd1b gene driven by the unc45b promoter fragment is able to rescue the embryonically lethal heart and skeletal muscle defects in smyd1b-deficient flatline mutant zebrafish. Our findings demonstrate that the described muscle-specific unc45b promoter fragment might be a valuable tool for the development of genetic therapies in patients suffering from myopathies. genesis 54:431-438, 2016. © 2016 The Authors. Genesis Published by Wiley Periodicals, Inc.

Indexed as

Promoter Regions, GeneticAnimalsDNA-Binding ProteinsFemaleMaleMiceMice, Inbred C57BLMuscle ProteinsMuscle, SkeletalMyocardiumOrgan SpecificityTranscription FactorsZebrafishDNA-Binding ProteinsMuscle ProteinsTranscription Factorsmusclemuscle diseasessmyd1bunc45bzebrafish

Identifiers

PMID27295336
PMCPMC5113797
OpenAlexW2432674711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.